Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: ₹0.14 M
• Last 3 months FTD volume: ₹1.1 M
• Last year FTD volume: ₹1.1 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	₹69.9 M	₹0.12 B	🇺🇸 USA
SIGA Technologies SIGA	₹0.7 M	₹6.34 M	🇺🇸 USA
GlaxoSmithKline GSK	₹94.71 M	₹0.14 B	🇬🇧 UK
Celldex Therapeutics CLDX	₹1.59 M	₹6.5 M	🇺🇸 USA
Pfizer PFE	₹21.73 M	₹0.33 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	₹15.72 M	₹40.98 M	🇮🇱 Israel
Soligenix SNGX	N/A	₹3.57 M	🇺🇸 USA